These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 9102224

  • 1. Wilms' tumor 1-KTS isoforms induce p53-independent apoptosis that can be partially rescued by expression of the epidermal growth factor receptor or the insulin receptor.
    Menke AL, Shvarts A, Riteco N, van Ham RC, van der Eb AJ, Jochemsen AG.
    Cancer Res; 1997 Apr 01; 57(7):1353-63. PubMed ID: 9102224
    [Abstract] [Full Text] [Related]

  • 2. Functional properties of WT1.
    Haber DA, Englert C, Maheswaran S.
    Med Pediatr Oncol; 1996 Nov 01; 27(5):453-5. PubMed ID: 8827073
    [Abstract] [Full Text] [Related]

  • 3. Wilms' tumor 1 splice variants have opposite effects on the tumorigenicity of adenovirus-transformed baby-rat kidney cells.
    Menke AL, Riteco N, van Ham RC, de Bruyne C, Rauscher FJ, van der Eb AJ, Jochemsen AG.
    Oncogene; 1996 Feb 01; 12(3):537-46. PubMed ID: 8637710
    [Abstract] [Full Text] [Related]

  • 4. The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Müllerian-inhibiting substance, and the androgen receptor.
    Shimamura R, Fraizer GC, Trapman J, Lau YfC, Saunders GF.
    Clin Cancer Res; 1997 Dec 01; 3(12 Pt 2):2571-80. PubMed ID: 9815658
    [Abstract] [Full Text] [Related]

  • 5. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
    Han Y, San-Marina S, Yang L, Khoury H, Minden MD.
    Breast Cancer Res; 2007 Dec 01; 9(4):R43. PubMed ID: 17634147
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, wt1, have altered DNA binding specificity and regulate transcription in different ways.
    Wang ZY, Qiu QQ, Huang J, Gurrieri M, Deuel TF.
    Oncogene; 1995 Feb 02; 10(3):415-22. PubMed ID: 7845666
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. WT1 induces expression of insulin-like growth factor 2 in Wilms' tumor cells.
    Nichols KE, Re GG, Yan YX, Garvin AJ, Haber DA.
    Cancer Res; 1995 Oct 15; 55(20):4540-3. PubMed ID: 7553624
    [Abstract] [Full Text] [Related]

  • 10. Analysis of WT1 target gene expression in stably transfected cell lines.
    Thäte C, Englert C, Gessler M.
    Oncogene; 1998 Sep 10; 17(10):1287-94. PubMed ID: 9771972
    [Abstract] [Full Text] [Related]

  • 11. [Inhibitory effect of WT1 gene isoform transfection on proliferation of leukemia cell line NB4].
    Shen HL, Chen ZX, Wang W, Cen JN, Hu SY, Zhao Y.
    Ai Zheng; 2006 Feb 10; 25(2):163-9. PubMed ID: 16480579
    [Abstract] [Full Text] [Related]

  • 12. A novel target for the Wilms' tumour suppressor protein (WT1) is bound by a unique combination of zinc fingers.
    Little MH, Holmes G, Pell L, Caricasole A, Duarte A, Law M, Ward A, Wainwright B.
    Oncogene; 1996 Oct 03; 13(7):1461-9. PubMed ID: 8875984
    [Abstract] [Full Text] [Related]

  • 13. Expression of the Wilms' tumor suppressor gene, WT1, reduces the tumorigenicity of the leukemic cell line M1 in C.B-17 scid/scid mice.
    Smith SI, Down M, Boyd AW, Li CL.
    Cancer Res; 2000 Feb 15; 60(4):808-14. PubMed ID: 10706085
    [Abstract] [Full Text] [Related]

  • 14. The desmoplastic small round cell tumor t(11;22) translocation produces EWS/WT1 isoforms with differing oncogenic properties.
    Kim J, Lee K, Pelletier J.
    Oncogene; 1998 Apr 16; 16(15):1973-9. PubMed ID: 9591781
    [Abstract] [Full Text] [Related]

  • 15. Differential regulation of the Wilms' tumor gene, WT1, during differentiation of embryonal carcinoma and embryonic stem cells.
    Scharnhorst V, Kranenburg O, van der Eb AJ, Jochemsen AG.
    Cell Growth Differ; 1997 Feb 16; 8(2):133-43. PubMed ID: 9040935
    [Abstract] [Full Text] [Related]

  • 16. Wilms' tumor gene WT1-shRNA as a potent apoptosis-inducing agent for solid tumors.
    Tatsumi N, Oji Y, Tsuji N, Tsuda A, Higashio M, Aoyagi S, Fukuda I, Ito K, Nakamura J, Takashima S, Kitamura Y, Miyai S, Jomgeow T, Li Z, Shirakata T, Nishida S, Tsuboi A, Oka Y, Sugiyama H.
    Int J Oncol; 2008 Mar 16; 32(3):701-11. PubMed ID: 18292948
    [Abstract] [Full Text] [Related]

  • 17. Antiapoptotic function of 17AA(+)WT1 (Wilms' tumor gene) isoforms on the intrinsic apoptosis pathway.
    Ito K, Oji Y, Tatsumi N, Shimizu S, Kanai Y, Nakazawa T, Asada M, Jomgeow T, Aoyagi S, Nakano Y, Tamaki H, Sakaguchi N, Shirakata T, Nishida S, Kawakami M, Tsuboi A, Oka Y, Tsujimoto Y, Sugiyama H.
    Oncogene; 2006 Jul 13; 25(30):4217-29. PubMed ID: 16518414
    [Abstract] [Full Text] [Related]

  • 18. Wilms tumor and the WT1 gene.
    Lee SB, Haber DA.
    Exp Cell Res; 2001 Mar 10; 264(1):74-99. PubMed ID: 11237525
    [Abstract] [Full Text] [Related]

  • 19. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
    Zaia A, Fraizer GC, Piantanelli L, Saunders GF.
    Anticancer Res; 2001 Mar 10; 21(1A):1-10. PubMed ID: 11299720
    [Abstract] [Full Text] [Related]

  • 20. Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy.
    Perugorria MJ, Castillo J, Latasa MU, Goñi S, Segura V, Sangro B, Prieto J, Avila MA, Berasain C.
    Cancer Res; 2009 Feb 15; 69(4):1358-67. PubMed ID: 19190340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.